Hyperparathyroidism
Navigation Links
Hyperparathyroidism in Medical News
... results from over 200 US Nephrologists. The survey was fielded in late May and focuses on trends in treatment patterns for renal anemia, secondary hyperparathyroidism and hyperphosphatemia.
Nephrologists are extremely interested in AMAG's new IV iron product, Feraheme, which was approved by the FDA on June ...
Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model
... D hormone replacement therapies, calcitriol and paricalcitol (Zemplar(R)), the latter currently being the most widely used therapy for secondary hyperparathyroidism (SHPT) in the United States (U.S.). These data were presented in a poster presentation entitled "The Metabolic Profile of CTA018 Confers Therapeutic ...Hyperparathyroidism in Medical Technology
Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
... CTA018 has potential as a treatment for secondary hyperparathyroidism in chronic kidney disease (CKD). Blood samples ... is expected to be effective in treating secondary hyperparathyroidism but safer than currently available therapies. ... analogues are currently used to treat secondary hyperparathyroidism in CKD and end-stage renal disease. According to ...Hyperparathyroidism in Medical Products
Description:... the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum ...
Company:Diagnostic Systems Laboratories, Inc.
Description:... the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum ...
Company:Diagnostic Systems Laboratories, Inc.
Company:Diagnostic Systems Laboratories, Inc.
Description:... the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum ...
Company:Diagnostic Systems Laboratories, Inc.
Hyperparathyroidism in Medical Definition
... ) - Hypoglycemia - Hyperinsulinism - Zollinger-Ellison syndrome
Parathyroid
Hypoparathyroidism ( Pseudohypoparathyroidism ) - hyperparathyroidism ( Primary , Secondary , Tertiary )
Pituitary
hyperfunction ( Acromegaly , Hyperprolactinaemia , Syndrome of inappropriate antidiuretic ...
Hyperparathyroidism in Medical Dictionary
... hyperparathyroidism is caused by overactive parathyroid glands . ... levels of calcium in the blood stream. hyperparathyroidism - The over production of parat hormone by the ... hormone in an increased quantity). Primary hyperparathyroidism involves excessive production of parathyroid ...
... thyroid gland . hypopituitarism ... Cure of hyperparathyroidism was achieved surgically in 89% of 1 large series ... . Five patients (9%) had recurrent hyperparathyroidism . Low levels of calcium in the blood can ... problem, namely hypoparathyroidism ... hyperparathyroidism , metastatic bone tumor , milk-alkali syndrome ...
... hyperplasia causes about 15% of cases of hyperparathyroidism , which leads to elevated levels of calcium in ... thyroid gland ; parathyroid glands ; ... hyperparathyroidism is caused by overactive parathyroid glands . ... diagnosis of overactive parathyroid glands ( hyperparathyroidism ). Primary ...
... levels of PTH , the hallmark of secondary hyperparathyroidism , are associated with altered metabolism of ... and make too much PTH , a condition called hyperparathyroidism . This causes too much calcium to be found in ... hormone ) levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal ... ...
... D analog indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure . Dosage/administration: Recommended initial dose is 0.04 mcg/kg to 0. Secondary hyperparathyroidism is often seen in patients with chronic renal failure (CRF). Chronic ...
... Names : Parathyroid-Related Hypercalcemia Definition Primary hyperparathyroidism involves excessive production of parathyroid hormone caused by ... levels. Hypercalcemia Abnormally high levels of blood calcium . hyperparathyroidism Overactivity of the parathyroid glands . Symptoms include generalized ...
... , rickets , bone tumors , or by overactive parathyroid glands ( hyperparathyroidism ). Normal healing of a bone fracture can also raise ALP levels. The ... and osteomalacia (both bone-weakening disease s). Another result of hyperparathyroidism is kidney stones , because of high levels of calcium excreted into the ...
... , diabetes mellitus , acromegaly and some ... Endocrine problems most often include premature puberty , but can also include acromegaly , hyperparathyroidism , Vitamin D -resistant rickets , hyperthyroidism , and Cushing Syndrome . ...
... . Secondary Aplastic Anemia secondary Cardiac Amyloidosis - AA Type ( Cardiac Amyloidosis ) Secondary Glaucoma ( Glaucoma ) Secondary hyperparathyroidism Secondary Hypogonadism (Hypogonadotropic Hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , aplastic anemia ...
... levels can be caused by bone diseases , such as Paget's disease , osteomalacia , rickets , bone tumors , or by overactive parathyroid glands ( hyperparathyroidism ). Normal healing of a bone fracture can also raise ALP levels. In fact, in one 2000 study, susceptibility to muscle and bone diseases was ...
... thyroid gland . hypopituitarism ... Cure of hyperparathyroidism was achieved surgically in 89% of 1 large series ... . Five patients (9%) had recurrent hyperparathyroidism . Low levels of calcium in the blood can ... problem, namely hypoparathyroidism ... hyperparathyroidism , metastatic bone tumor , milk-alkali syndrome ...
... hyperplasia causes about 15% of cases of hyperparathyroidism , which leads to elevated levels of calcium in ... thyroid gland ; parathyroid glands ; ... hyperparathyroidism is caused by overactive parathyroid glands . ... diagnosis of overactive parathyroid glands ( hyperparathyroidism ). Primary ...
... levels of PTH , the hallmark of secondary hyperparathyroidism , are associated with altered metabolism of ... and make too much PTH , a condition called hyperparathyroidism . This causes too much calcium to be found in ... hormone ) levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal ... ...
... D analog indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure . Dosage/administration: Recommended initial dose is 0.04 mcg/kg to 0. Secondary hyperparathyroidism is often seen in patients with chronic renal failure (CRF). Chronic ...
... Names : Parathyroid-Related Hypercalcemia Definition Primary hyperparathyroidism involves excessive production of parathyroid hormone caused by ... levels. Hypercalcemia Abnormally high levels of blood calcium . hyperparathyroidism Overactivity of the parathyroid glands . Symptoms include generalized ...
... , rickets , bone tumors , or by overactive parathyroid glands ( hyperparathyroidism ). Normal healing of a bone fracture can also raise ALP levels. The ... and osteomalacia (both bone-weakening disease s). Another result of hyperparathyroidism is kidney stones , because of high levels of calcium excreted into the ...
... , diabetes mellitus , acromegaly and some ... Endocrine problems most often include premature puberty , but can also include acromegaly , hyperparathyroidism , Vitamin D -resistant rickets , hyperthyroidism , and Cushing Syndrome . ...
... . Secondary Aplastic Anemia secondary Cardiac Amyloidosis - AA Type ( Cardiac Amyloidosis ) Secondary Glaucoma ( Glaucoma ) Secondary hyperparathyroidism Secondary Hypogonadism (Hypogonadotropic Hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , aplastic anemia ...
... levels can be caused by bone diseases , such as Paget's disease , osteomalacia , rickets , bone tumors , or by overactive parathyroid glands ( hyperparathyroidism ). Normal healing of a bone fracture can also raise ALP levels. In fact, in one 2000 study, susceptibility to muscle and bone diseases was ...
Hyperparathyroidism in Biological Technology
... an important validation of our novel approach to
treating secondary hyperparathyroidism in CKD patients."
MTPC's President and Representative Director, Natsuki ... in countries worldwide.
About Secondary Hyperparathyroidism
Secondary hyperparathyroidism ("SHPT") is a condition commonly
associated with chronic kidney disease ...
... these patients have vitamin D insufficiency, which can lead to secondary hyperparathyroidism and resultant debilitating bone diseases. There is growing evidence that ... portfolio of new therapies for Vitamin D insufficiency and secondary hyperparathyroidism associated with CKD. In addition, the Company is developing novel ...
... require dialysis. Phosphate retention and the resulting hyperphosphatemia in patients with ESRD on dialysis are usually associated with secondary hyperparathyroidism (and its related cardiovascular complications), renal osteodystrophy and soft tissue mineralization. ESRD patients usually require treatment with ...
... commercializing improved vitamin D-hormone therapies to treat secondary hyperparathyroidism in patients with kidney (renal) disease, osteoporosis and psoriasis. The ... Injection and Hectorol(R) Capsules for the treatment of secondary hyperparathyroidism in patients with end-stage renal ....
... these patients have vitamin D insufficiency, which can lead to secondary hyperparathyroidism and resultant debilitating bone diseases. There is growing evidence that ... portfolio of new therapies for Vitamin D insufficiency and secondary hyperparathyroidism associated with CKD. In addition, the Company is developing novel ...
... require dialysis. Phosphate retention and the resulting hyperphosphatemia in patients with ESRD on dialysis are usually associated with secondary hyperparathyroidism (and its related cardiovascular complications), renal osteodystrophy and soft tissue mineralization. ESRD patients usually require treatment with ...
Cytochroma Closes $45 Million Series C Financing
... related to altered vitamin D metabolism in chronic kidney disease ("CKD") patients, and include CTA018 and CTAP201 for the treatment of secondary hyperparathyroidism ("SHPT"), and CTAP101 for the treatment of vitamin D insufficiency. These three lead products address significant markets that are expected to grow ...Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
... has acquired ROCALTROL(R) (calcitriol) from Roche Laboratories Inc. ROCALTROL is a vitamin D analog prescribed by nephrologists for the management of hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (CRF) and by endocrinologists for the management of ...Cytochroma Appoints R. Richard Wieland II As CFO
... has three lead product candidates in development for CKD patients: CTA018 and CTAP201 are being developed for the treatment of secondary hyperparathyroidism (SHPT), while CTAP101 is being developed for the treatment of Vitamin D insufficiency. About Chronic Kidney Disease According to the National ...Cytochroma opens U.S. headquarters in Illinois
... has three lead product candidates in development for CKD patients: CTA018 and CTAP201 are being developed for the treatment of secondary hyperparathyroidism (SHPT), while CTAP101 is being developed for the treatment of Vitamin D insufficiency. About Chronic Kidney Disease According to the National ...Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
... for vitamin D deficiency and secondary hyperparathyroidism in patients with moderate-to-severe CKD. ... hyperparathyroidism. If untreated, secondary hyperparathyroidism can cause debilitating bone diseases and ... and preventing vitamin D deficiency and secondary hyperparathyroidism in CKD patients, but Dr. Geoffrey A. Block, ...... commercializing improved vitamin D-hormone therapies to treat secondary hyperparathyroidism in patients with kidney (renal) disease, osteoporosis and psoriasis. The ... Injection and Hectorol(R) Capsules for the treatment of secondary hyperparathyroidism in patients with end-stage renal ....
Americas Third Coast nurtures biotechnology
... ) specializes in novel vitamin D therapies for people with chronic kidney disease (CKD). The companys main drug, Hectorol, treats secondary hyperparathyroidism (SHPT) in patients with CKD. Healthy kidneys produce D hormone, which regulates calcium balance. Left untreated, low D hormone levels often ...Hyperparathyroidism in Biological Dictionary
... producing an excess ... Parathyroid Glands • hyperparathyroidism Treatments • hyperparathyroidism Surgery • Contact Us ... Easy to understand ... Your Parathyroid Glands . Hypoparathyroidism. hyperparathyroidism ... Fortunately for most people, most of the ...
Other ContentschickenchickenchickenchickenchickenchickenpoxchickenpoxchillchillchillchildchildchildchildchildchildchildchildchildchildbirthchildbirthchillschillschlamydiachlamydiachlamydiachlamydiaOther TagsJAMA
(Date:11/25/2009)...NTURA,Fla.,Nov.25/PRNewswire/--DanielTouizer,CEOof...ranteedissuehealthinsurancebenefitprograms,isconce...bermeansnearlyoneinfiveAmericansarewithoutafull-ti...unemploymentratesaredeterminedbytheU-6number,which... Dani e l T ouizer ."Thesestatisticsarealarm...
(Date:11/25/2009)...ease is available in French and Spanish . ,... have provided an early diagnosis of certain ocul...e-related macular degeneration and keratitis, by a...heless, had never before been used for this purpos...image quality in subjects affected by one of these...
(Date:11/25/2009)...ss release is available in French . , , Mont... are about to enter the marketplace, thanks to a n...artnership (Univalor) and Cognitive Sensing Inc. (...n Montreal. , Univalor, which commercializes dis...iliated institutions, and CSI have announced the s...
(Date:11/25/2009)...n fruit fly study may lead to new drugs for people... (HealthDay News) -- Sphingadienes, natural lipid ...ent in treatments for colon cancer, California res...inary, but the study authors pointed out that they...ction against colon cancer. , In the study, Dr....
(Date:11/25/2009)... offer waistline-friendly ways to enjoy festive fe... News) -- If you love the five-week holiday smorga...eady stressing about the added pounds you,ll have ...,s possible, say nutrition experts, to enjoy holid...as you do today. , It,s all about devising a s...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:Natural Soy Component May Help Treat Colon Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3[0] Cinergy Health Commentary on Health Care for the Unemployed[0] Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration[0] Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries[0] Natural Soy Component May Help Treat Colon Cancer[0] Holiday Eating Without the Guilt -- or the Pounds
(Date:11/23/2009)...TINew research presents strong evidence that the "... outdoor traffic-related pollution and indoor endo...e or the other exposure alone. , Environmental... (UC) College of Medicine have shown that children...rticles and indoor endotoxin during early life are...
(Date:11/23/2009)...O, November 23, 2009 - The time of day matters to ...new paper produced by a research team led by Profe...orough,s vice-principal for research and colleague... the St. George campus. , Capitalizing on thei... tree, the research team examined how poplar trees...
(Date:11/23/2009)...on, CT Current research suggests that a common or...he related report by Nichols et al, "Unique Lipids...ss of TLR2 Ligands Capable of Enhancing Autoimmuni...erican Journal of Pathology . , Multiple scleros... the brain and spinal cord, affects nearly 1 in 70...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 1Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 3Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 4Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 6Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 7Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 8Tamoxifen May Up Risk of Second More Aggressive Breast Cancer 55316 1Tamoxifen May Up Risk of Second More Aggressive Breast Cancer 55316 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 1SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 4PRT054021ASSERTTerminatesJAMASynovateGuanilibIntendsMitigatorCBLB502ProtectanEntraregEnteregAlvimopanAdolor
Other Tagsself 2will 2will 3will 4will 5will 6will 7will 8will 9will 10marine 2marine 3marine 4marine 5marine 6marine 7marine 8marine 9marine 10program 2program 3program 4program 5program 6program 7program 8program 9program 10service 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |